Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

Clinical trial NCT07047885 · RECRUITING

Trial details

NCT number: NCT07047885
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous T Cell Lymphoma

Start date: 2025-08-27
Primary completion: 2028-06-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.